JPMorgan Chase Agents $600MM in Term Loans for Catalent
Catalent Pharma Solutions entered into an amendment to its existing credit agreement for the issuance of $600 million in incremental term loans. According to an 8K filed with the SEC, JPMorgan Chase is the administrative agent, collateral agent, swing line lender and letter of credit issuer.
December 20, 2023
Catalent | Catalent Pharma Solutions | JPMorgan Chase | Matti Masanovich
Ian Koplin